News
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
The Trump administration is reportedly considering a way to ease Medicare and Medicaid into covering GLP-1 drugs like Ozempic ...
A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic, were linked to a 33% lower risk of ...
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results